Emerging Trends and Dynamics in Shigella Vaccines Development and Commercialization
The global healthcare sector is witnessing significant advancements in the development of Shigella vaccines, driven by the urgent need to address the burden of shigellosis, a common bacterial infection causing diarrhea and dysentery globally. Shigella, a genus of bacteria responsible for severe gastrointestinal illnesses, particularly affects children in low- and middle-income countries, leading to high morbidity and, in some cases, mortality rates. The rising antibiotic resistance and the lack of an effective licensed vaccine have intensified the focus on innovative vaccine candidates, highlighting a lucrative yet challenging segment within the vaccine industry.
Shigella Vaccines - https://www.coherentmarketinsights.com/market-insight/shigella-vaccines-market-1110